result better fear fact larg line
expect organ revenu growth line pre-announc
driven strong growth lss sdx lp divis grew
averag ai signific off-set result build confid well-posit
weather headwind
confer call et dial passcod none
report revenu y/i report y/i organ exceed
consensu forecast howev sell-sid estim rang quit wide
organ revenu growth line pre-announc
organ revenu growth exceed consensu estim rang
estim quit wide
remind march materi cut forecast reflect
conserv plausibl downsid scenario set assumpt outlin detail report
publish day link time pre-announc clear
held much better fear end
rel origin forecast prior march busi segment
ai exceed expect life scienc solut lss revenu y/i
organ ahead forecast specialti diagnost sdx revenu
y/i organ net anatom patholog divestitur ahead forecast
lab product servic lp revenu y/i organ
better expect aggreg estim organ growth
segment sourc upsid off-set revenu
y/i organ come light origin forecast
ep y/i beat origin forecast gross margin
oper margin line origin forecast
believ result consist belief lever busi area
diagnost test suppli lab/hospit equip etc better origin expect
busi insul headwind drug manufacturing/
click link full report
said focus capit instrument demand trend march earli
april geograph trend given pace pandem differ region
april sign consum suppli stock especi lp custom behavior
end market product capac meet relat demand beyond
revenu drivers/headwind look detail oper plan evolv
period uncertainti
pleas see page report import disclosur
compani report thomson eikon cowen compani
cowen vs consensu mm except organ fx larg bit net gross roughli flat gross margin y/i headwind reinvest due debt refi pct fy fy revenu metric mm except scienc product statement mm except currenc per count significantli better adjust forecast bit better origin forecast oper margin larg line origin forecast higher adjust forecast sg expens lower forecast expens lower forecast gross margin larg line forecast streetaccount consensu organ report revenu y/i report y/i organ exceed consensu forecast howev sell-sid estim rang quit wide organ revenu growth line pre-announc organ revenu growth exceed consensu estim rang estim quit wide consensu lp organ revenu growth much better expect believ demand like held potenti order pull forward streetaccount consensu sdx organ revenu growth much better expect believ sale hospital/diagnost equip transport media swab ppe key sourc revenu growth streetaccount consensu ai organ revenu declin wors expect like custom accept instrument placement streetaccount consensu lss organ revenu growth much better expect believ growth driven strong bioproduct pcr demand diagnost base recent peer commentari believ stock particularli within bioproduct also like drove organ revenu growth cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit macroeconom deterior current
level inabl execut integr eros market share price due
competit inabl deliv incremental/decrement margin target value-
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc april et dissemin april et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
